PT Kalbe Farma Tbk (PTKFF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
PT Kalbe Farma Price to Book Value : 1.743 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.743 |
| August 27, 2026 | 1.743 |
| August 26, 2026 | 1.743 |
| August 25, 2026 | 1.743 |
| August 24, 2026 | 1.743 |
| August 21, 2026 | 1.743 |
| August 20, 2026 | 1.743 |
| August 19, 2026 | 1.338 |
| August 18, 2026 | 1.338 |
| August 17, 2026 | 1.338 |
| August 14, 2026 | 1.338 |
| August 13, 2026 | 1.338 |
| August 12, 2026 | 1.338 |
| August 11, 2026 | 1.338 |
| August 10, 2026 | 1.338 |
| August 07, 2026 | 1.338 |
| August 06, 2026 | 1.338 |
| August 05, 2026 | 1.338 |
| August 04, 2026 | 1.338 |
| August 03, 2026 | 1.338 |
| July 31, 2026 | 1.338 |
| July 30, 2026 | 1.338 |
| July 29, 2026 | 1.338 |
| July 28, 2026 | 1.338 |
| July 27, 2026 | 1.338 |
| Date | Value |
|---|---|
| July 24, 2026 | 1.338 |
| July 23, 2026 | 1.338 |
| July 22, 2026 | 1.338 |
| July 21, 2026 | 1.338 |
| July 20, 2026 | 1.338 |
| July 17, 2026 | 1.338 |
| July 16, 2026 | 1.338 |
| July 15, 2026 | 1.338 |
| July 14, 2026 | 1.338 |
| July 13, 2026 | 1.338 |
| July 10, 2026 | 1.338 |
| July 09, 2026 | 1.338 |
| July 08, 2026 | 1.338 |
| July 07, 2026 | 1.338 |
| July 06, 2026 | 1.338 |
| July 02, 2026 | 1.338 |
| July 01, 2026 | 1.338 |
| June 30, 2026 | 1.338 |
| June 29, 2026 | 1.274 |
| June 26, 2026 | 1.274 |
| June 25, 2026 | 1.274 |
| June 24, 2026 | 1.274 |
| June 23, 2026 | 1.274 |
| June 22, 2026 | 1.274 |
| June 18, 2026 | 1.274 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.66 |
| ANI Pharmaceuticals, Inc. | 2.802 |
| Corcept Therapeutics, Inc. | 17.41 |
| Veru, Inc. | 1.577 |
| Avadel Pharmaceuticals Plc | -- |
Price to Book Value Related Metrics
| PE Ratio | 11.15 |
| PS Ratio | 1.060 |
| PEG Ratio | 5.128 |
| Price to Free Cash Flow | 16.34 |
| Price | 0.0524 |
| Earnings Yield | 8.97% |
| Market Cap | 2.371B |
| PEGY Ratio | 2.586 |
| Operating PE Ratio | 8.734 |
| Normalized PE Ratio | 11.15 |